Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Biomedical Engineering
U.S. NIH selects Vanderbilt University for new molecular screening center
July 24th, 2005
The U.S. National Institutes for Health announced that Vanderbilt University was one of the centers chosen for the new Molecular Libraries Screening Centers Network (MLSCN), part of the NIH Roadmap Initiative. "Molecular library screening will give academic researchers the ability to combine high throughput approaches with unique biology to rapidly find small molecule modulators of targets and processes," said Dr. Dave Weaver, director of the Molecular Recognition and Screening Facility at the Vanderbilt Institute of Chemical Biology and a research assistant professor of pharmacology. "Only in the past few years has high-throughput screening become...
Source: Medical Letter on the CDC & FDA (2005-07-24)
|
